Guangxitoxin

From WikiMD's WELLNESSPEDIA

Guangxitoxin is a neurotoxin that is derived from the venom of the Chinese bird spider Haplopelma schmidti. It is a potent blocker of voltage-gated potassium channels, specifically the Kv2.1 channel, and has been used in scientific research to study the function and pharmacology of these channels.

Structure and Function[edit]

Guangxitoxin is a peptide toxin composed of 35 amino acids. It has a compact, stable structure that is maintained by three disulfide bonds. The toxin binds to the outer vestibule of the Kv2.1 channel, blocking the passage of potassium ions and thereby inhibiting the function of the channel.

Pharmacology[edit]

The Kv2.1 channel is widely expressed in the nervous system, and plays a crucial role in regulating neuronal excitability. By blocking this channel, guangxitoxin can significantly alter neuronal function. This has made it a valuable tool in the study of the Kv2.1 channel and its role in the nervous system.

In addition to its effects on the Kv2.1 channel, guangxitoxin has also been found to block other types of potassium channels, although with less potency. This broad-spectrum activity has led to its use in the study of other potassium channels and their roles in physiology and disease.

Toxicity[edit]

As a neurotoxin, guangxitoxin is highly toxic and can cause severe symptoms if ingested or injected. These can include muscle paralysis, respiratory failure, and death. However, its toxicity can be reduced by proper handling and storage, and it is generally safe to use in a laboratory setting under appropriate safety precautions.

Research Applications[edit]

Guangxitoxin has been used in a wide range of research applications. These include studies of the structure and function of the Kv2.1 channel, investigations of the role of this channel in neuronal excitability and signaling, and the development of new drugs targeting this channel.

See Also[edit]

References[edit]


This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.